Researchers find new driver of an aggressive form of brain cancer

November 15, 2016, University of Hawaii at Manoa
Study lead author. Credit: UHCancerCenter

University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age. The discovery can help researchers create novel targeted therapies potentially reducing deaths from this devastating cancer.

"New treatment options for patients are desperately needed," said Joe W. Ramos, UH Cancer Center deputy director and lead researcher on the study. "Treatment options include chemotherapy in combination with radiation, but they only prolong a patient's life by a few months."

Glioblastoma remains a lethal with only a 14-month average survival rate after initial diagnosis.

The study published in Oncotarget reveals that a protein called RSK2 is increased in many patients with glioblastoma. The protein pushes glioblastoma cells into surrounding healthy brain tissue. The invasion of these cells throughout the brain makes it difficult to remove the tumor by surgery, which contributes to high recurrence and poor survival rates in patients. The invading glioblastoma cells are less sensitive to current standard therapies. The research team found that inhibiting RSK2 stops invasion of the and enhances the effectiveness of standard chemotherapy in tumor cells obtained from patients.

"This study paves the way for development of new brain cancer therapies focused on RSK2 inhibitors for brain invasion," said co-author Santosh Kesari, chair of Department of Translational Neurosciences and Neurotherapeutics of the John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center.

"The next steps include identifying better compounds to target the RSK2 protein.

We are hoping to discover a powerful new drug to treat this aggressive brain cancer," said Ramos.

The findings resulted from several years of collaboration among the labs of Ramos and Michelle Matter at the UH Cancer Center, Kesari at the John Wayne Cancer Institute, and Dirk Geerts of Erasmus University Medical Center in the Netherlands.

"The new discovery can potentially lead to a new class of drugs to treat not only brain cancers, but other invasive cancers as well. With about 60 new cases of brain cancer diagnosed every year in Hawai'i, and about 40 deaths, an effective treatment can help many patients in our state," said Randall Holcombe, UH Cancer Center director.

Explore further: Researchers discover protein that may control the spread of cancer

More information: Florian J. Sulzmaier et al, RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics, Oncotarget (2016). DOI: 10.18632/oncotarget.13084

Related Stories

Researchers discover protein that may control the spread of cancer

February 26, 2013
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...

Study targets SGEF protein in treating glioblastoma brain tumors

January 13, 2016
The Translational Genomics Research Institute (TGen) has identified a protein called SGEF that promotes the survival of glioblastoma tumor cells and helps the cancer invade brain tissue.

Team identifies drug that could limit the spread of deadly brain tumors

November 12, 2015
In a significant breakthrough, the Translational Genomics Research Institute (TGen) has identified a drug, propentofylline or PPF, that could help treat patients with deadly brain cancer.

Compounds show potential in fighting brain and breast cancers

July 15, 2015
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumors, opening the way for potential new drugs to be developed.

Researchers create a promising new treatment for the deadliest form of brain cancer

September 2, 2015
UCLA scientists have developed a potentially promising new combination therapy for glioblastoma, the most common and deadliest form of brain cancer.

Team discovers mechanism responsible for tumor invasion in brain cancer

April 9, 2015
A neuro-oncology research team at Dartmouth's Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of ...

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.